日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

EVEREST study report 4: Fluorescein angiography features predictive of polypoidal choroidal vasculopathy

EVEREST 研究报告 4：预测息肉状脉络膜血管病变的荧光素血管造影特征

期刊:Clinical and Experimental Ophthalmology
影响因子:5.6
doi:10.1111/ceo.13464
Tan, Colin S; Ngo, Wei K; Lim, Louis W; Tan, Nikolle W; Lim, Tock H
REST
IF
发表日期：2019
文献求助 收藏

LONG-TERM OUTCOMES OF RANIBIZUMAB TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION IN EAST-ASIAN PATIENTS FROM THE RADIANCE STUDY

来自 RADIANCE 研究的东亚患者接受雷珠单抗治疗近视性脉络膜新生血管的长期疗效

期刊:Retina-The Journal of Retinal and Vitreous Diseases
影响因子:2.1
doi:10.1097/IAE.0000000000001858
Tan, Nikolle W; Ohno-Matsui, Kyoko; Koh, Hyoung J; Nagai, Yoshimi; Pedros, Montse; Freitas, Rita L; Macfadden, Wayne; Lai, Timothy Y
发表日期：2018
文献求助 收藏

EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study

EVEREST 研究报告 3：息肉状脉络膜血管病变的诊断挑战。从 EVEREST 研究筛查失败中吸取的教训

期刊:Graefes Archive for Clinical and Experimental Ophthalmology
影响因子:2.3
doi:10.1007/s00417-016-3333-y
Tan, Colin S; Ngo, Wei Kiong; Lim, Louis W; Tan, Nikolle W; Lim, Tock H
REST
发表日期：2016
文献求助 收藏

EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy.

EVEREST 研究报告 2：息肉状脉络膜血管病变随机对照试验的成像和分级方案及基线特征

期刊:British Journal of Ophthalmology
影响因子:3.5
doi:10.1136/bjophthalmol-2014-305674
Tan Colin S, Ngo Wei Kiong, Chen Jian Ping, Tan Nikolle W, Lim Tock Han
心血管
发表日期：2015
文献求助 收藏